NCT02858310 2026-03-09
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
Clinical Trials
23 trialsNCT07416825 2026-02-18
Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19
Institute of Oncology Ljubljana
Phase NA Completed
NCT02356159 2025-09-30
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT04186845 2025-09-22
Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence
Blue Earth Diagnostics
Phase 3 Completed
NCT00924027 2025-09-05
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT05012098 2025-08-08
Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00001337 2025-06-22
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03824535 2025-04-09
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Stanford University
Phase 2 Completed
NCT04186819 2025-02-26
Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.
Blue Earth Diagnostics
Phase 3 Completed
NCT04510311 2025-01-10
Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Completed
NCT02023996 2024-12-10
PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT02492867 2024-09-03
A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT02683824 2023-09-21
Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers
Stanford University
Phase EARLY_PHASE1 Completed
NCT03352037 2021-04-19
18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot Study
University Health Network, Toronto
Phase NA Completed
NCT03125629 2021-04-09
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
Stanford University
Phase 2 Completed
NCT02611882 2020-12-22
PSMA PET
University of California, San Francisco
Phase 2 Completed
NCT02018107 2020-03-26
PET/CT-Assessment of Liver Tumor Ablation
Dana-Farber Cancer Institute
Phase NA Completed
NCT02084147 2019-10-29
PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
Case Comprehensive Cancer Center
Phase NA Completed
NCT01205646 2019-04-12
PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Phase NA Completed
NCT02717572 2019-04-05
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Washington University School of Medicine
Phase 1 Completed
NCT01395030 2018-09-26
PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection
Queen's Medical Center
Phase 2 Completed
NCT01207895 2017-02-23
Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer
Vanderbilt-Ingram Cancer Center
Phase 1 Completed
NCT02437539 2015-08-24
uPAR-PET
Rigshospitalet, Denmark
Phase 1 Completed